The Oncolytic Virotherapy Era in Cancer Management: Prospects of Applying H-1 Parvovirus to Treat Blood and Solid Cancers.

Angelova, Assia L; Witzens-Harig, Mathias; Galabov, Angel S; Rommelaere, Jean.

Afiliação

Angelova AL; Department of Tumor Virology, German Cancer Research Center, Heidelberg, Germany.
Witzens-Harig M; Department of Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany.
Galabov AS; Department of Virology, The Stephan Angeloff Institute of Microbiology, Bulgarian Academy of Sciences, Sofia, Bulgaria.
Rommelaere J; Department of Tumor Virology, German Cancer Research Center, Heidelberg, Germany.

Front Oncol ; 7: 93, 2017.

Article em En | MEDLINE | ID: mdl-28553616

Palavras-chave

cutaneous T-cell lymphoma; diffuse large B-cell lymphoma; glioblastoma; oncolytic (parvo)virotherapy of hematological malignancies; oncolytic H-1 parvovirus; oncolytic virotherapy; pancreatic ductal adenocarcinoma

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2017 Tipo de documento: Article